FTFinancial Times·3hBusiness
score-0.55
Boehringer Ingelheim Calls for Pricing Reform to Keep Europe Competitive in Global Pharma Race
Original
Europe’s pharma industry risks lagging behind US and China, says German drugmaker
“Uses competitive framing ('risks lagging') and regulatory criticism ('hinders access') to emphasize European disadvantage and systemic constraints.”